Analysts expect over 2020 decreasing revenue Biogen

Over the current book year the total revenue will be 13,53 billion USD (consensus estimates). This is slightly lower than 2019's revenue of 14,38 billion USD.

Historical revenues and results Biogen plus estimates 2020

The analysts expect for 2020 a net profit of 5,5 billion USD. The majority of the analysts expects for this year a profit per share of 34,01 USD. Based on this the price/earnings-ratio is 7,91.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a moderate 0,31 percent.

Based on the current number of shares Biogen's market capitalization equals 53,03 billion USD. The Biogen stock was the past 12 months quite volatile. Since last October the stock is 4 percent lower. This year the stock price moved between 258 and 375 dollar.

Historical stock prices Biogen past 10 years

Click here for dividend Biogen. On Monday the stock closed at 268,91 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.